|
|
 |
|
Viewing report
|
|
|
|
Progenics Pharmaceuticals, Inc. - SWOT Analysis
Datamonitor, Oct 2009, Pages: 25
The Progenics Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Progenics Pharmaceuticals, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Progenics Pharmaceuticals (Progenics) is a biopharmaceutical company engaged in the development and commercialization of therapeutic products to meet the medical needs in the areas of supportive care, virology and oncology. Progenics is developing Relistor (methylnaltrexone bromide) for the treatment of opioid-induced side effects. Relistor is currently approved in over 30 countries. The company primarily operates in the US. It is headquartered in Tarrytown, New York and employed 244 people as of December 2008. The company recorded revenues of $69.9 million during the financial year (FY) ended December 2008, a decrease of 7.6% over FY2007. The operating loss of the company was $29.3 million during FY2008, as compared to the operating loss of $51.5 million in FY2007. The net loss of the company was $21.6 million in FY2008, as compared to the net loss of $43.7 million in FY2007.
Scope of the Report
- Provides all the crucial information on Progenics Pharmaceuticals, Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Progenics Pharmaceuticals, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Progenics Pharmaceuticals, Inc.
-Data is supplemented with details on Progenics Pharmaceuticals, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Progenics Pharmaceuticals, Inc.
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Customers who bought this item also bought
Progenics Pharmaceuticals, Inc.
Premium Company Profile Progenics Pharmaceuticals
Analysis of Progenics Pharmaceuticals
Progenics Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals - SWOT Framework Analysis
Progenics Pharmaceuticals Inc-Therapeutic Competitors
Isis Pharmaceuticals, Inc.
Idenix Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc. - SWOT Analysis
Vertex Pharmaceuticals, Inc. - SWOT Analysis
Auxilium Pharmaceuticals, Inc. - SWOT Analysis
|
|
|
|
